In gastric cancer (GC) tRF-24-V29K9UV3IU and tRF-3019a inhibit tumor cell migration and invasion and promote apoptosis [68, 72], while in hepatocellular carcinoma, Gly-tRF promotes cell migration and epithelial to mesenchymal transition (EMT) by binding to the 3′UTR of NDFIP2 mRNA [73]. The gene discussed is NDFIP2; the disease is hepatocellular carcinoma.